Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Nederlands Tijdschrift Voor Geneeskunde|June 9, 2004
[Megacolon during treatment with lactulose]H J van der Vliet, A A van Bodegraven
Scandinavian Journal of Gastroenterology. Supplement|January 28, 2004
Haemostasis in inflammatory bowel diseases: clinical relevanceA A van Bodegraven
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 12, 2019
Perspective on skeletal health in inflammatory bowel diseaseA A van Bodegraven, N Bravenboer
European Journal of Gastroenterology & Hepatology|December 14, 2001
Lipoprotein (a), thrombophilia and inflammatory bowel diseaseA A van Bodegraven, S G Meuwissen
Nederlands Tijdschrift Voor Geneeskunde|March 9, 2005
[Energy losses from a short bowel: not only fat]N J Wierdsma, A A van Bodegraven
World Journal of Gastroenterology|October 13, 2006
Indications for 5-aminosalicylate in inflammatory bowel disease: is the body of evidence complete?A A van Bodegraven, Chris J J Mulder
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2017
Statistical controversies in clinical research: overlap and errors in the meta-analyses of microRNA genetic association studies in cancersJ H Park, M Eisenhut, H J van der Vliet, et al.
Clinical Laboratory|October 13, 2001
Reduction of preanalytical errors due to in vitro activation of coagulationP C Bartels, M Schoorl, A A van Bodegraven
Clinical Immunology (Orlando, Fla.)|July 24, 2001
Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damageH J van der Vliet, B M von Blomberg, N Nishi, et al.
The Netherlands Journal of Medicine|June 1, 1993
Eosinophilic gastroenteritis--a disease with a wide clinical spectrumA Beishuizen, A A van Bodegraven, W Bronsveld, et al.
Pageof 8